#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Initial Mutations Direct Alternative Pathways of Protein Evolution


Whether evolution is erratic due to random historical details, or is repeatedly directed along similar paths by certain constraints, remains unclear. Epistasis (i.e. non-additive interaction between mutations that affect fitness) is a mechanism that can contribute to both scenarios. Epistasis can constrain the type and order of selected mutations, but it can also make adaptive trajectories contingent upon the first random substitution. This effect is particularly strong under sign epistasis, when the sign of the fitness effects of a mutation depends on its genetic background. In the current study, we examine how epistatic interactions between mutations determine alternative evolutionary pathways, using in vitro evolution of the antibiotic resistance enzyme TEM-1 β-lactamase. First, we describe the diversity of adaptive pathways among replicate lines during evolution for resistance to a novel antibiotic (cefotaxime). Consistent with the prediction of epistatic constraints, most lines increased resistance by acquiring three mutations in a fixed order. However, a few lines deviated from this pattern. Next, to test whether negative interactions between alternative initial substitutions drive this divergence, alleles containing initial substitutions from the deviating lines were evolved under identical conditions. Indeed, these alternative initial substitutions consistently led to lower adaptive peaks, involving more and other substitutions than those observed in the common pathway. We found that a combination of decreased enzymatic activity and lower folding cooperativity underlies negative sign epistasis in the clash between key mutations in the common and deviating lines (Gly238Ser and Arg164Ser, respectively). Our results demonstrate that epistasis contributes to contingency in protein evolution by amplifying the selective consequences of random mutations.


Vyšlo v časopise: Initial Mutations Direct Alternative Pathways of Protein Evolution. PLoS Genet 7(3): e32767. doi:10.1371/journal.pgen.1001321
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1001321

Souhrn

Whether evolution is erratic due to random historical details, or is repeatedly directed along similar paths by certain constraints, remains unclear. Epistasis (i.e. non-additive interaction between mutations that affect fitness) is a mechanism that can contribute to both scenarios. Epistasis can constrain the type and order of selected mutations, but it can also make adaptive trajectories contingent upon the first random substitution. This effect is particularly strong under sign epistasis, when the sign of the fitness effects of a mutation depends on its genetic background. In the current study, we examine how epistatic interactions between mutations determine alternative evolutionary pathways, using in vitro evolution of the antibiotic resistance enzyme TEM-1 β-lactamase. First, we describe the diversity of adaptive pathways among replicate lines during evolution for resistance to a novel antibiotic (cefotaxime). Consistent with the prediction of epistatic constraints, most lines increased resistance by acquiring three mutations in a fixed order. However, a few lines deviated from this pattern. Next, to test whether negative interactions between alternative initial substitutions drive this divergence, alleles containing initial substitutions from the deviating lines were evolved under identical conditions. Indeed, these alternative initial substitutions consistently led to lower adaptive peaks, involving more and other substitutions than those observed in the common pathway. We found that a combination of decreased enzymatic activity and lower folding cooperativity underlies negative sign epistasis in the clash between key mutations in the common and deviating lines (Gly238Ser and Arg164Ser, respectively). Our results demonstrate that epistasis contributes to contingency in protein evolution by amplifying the selective consequences of random mutations.


Zdroje

1. KondrashovFA

KondrashovAS

2001 Multidimensional epistasis and the disadvantage of sex. Proc Natl Acad Sci U S A 98 12089 12092

2. ManiGS

ClarkeBC

1990 Mutational order - a major stochastic process in evolution. Proc R Soc Biol Sci Ser B 240 29 37

3. de VisserJAGM

LenskiRE

2002 Long-term experimental evolution in Escherichia coli. XI. Rejection of non-transitive interactions as cause of declining rate of adaptation. BMC Evol Biol 2 19

4. MacLeanRC

PerronGG

GardnerA

2010 Diminishing returns from beneficial mutations and pervasive epistasis shape the fitness landscape for rifampicin resistance in Pseudomonas aeruginosa. Genetics 186 1345 1354

5. WeinreichDM

WatsonRA

ChaoL

2005 Perspective: sign epistasis and genetic constraint on evolutionary trajectories. Evolution 59 1165 1174

6. PoelwijkFJ

KivietDJ

WeinreichDM

TansSJ

2007 Empirical fitness landscapes reveal accessible evolutionary paths. Nature 445 383 386

7. WeinreichDM

ChaoL

2005 Rapid evolutionary escape by large populations from local fitness peaks is likely in nature. Evolution 59 1175 1182

8. de VisserJAGM

ParkS.-C

KrugJ

2009 Exploring the effect of sex on empirical fitness landscapes. Am Nat 174 s15 s30

9. WeissmanDB

FeldmanMW

FisherDS

2010 The rate of fitness-valley crossing in sexual populations. Genetics 186 1389 1410

10. PovolotskayaIS

KondrashovFA

2010 Sequence space and the ongoing expansion of the protein universe. Nature 465 922 926

11. WichmanHA

BadgettMR

ScottLA

BoulianneCM

BullJJ

1999 Different trajectories of parallel evolution during viral adaptation. Science 285 422 424

12. BollbackJP

HuelsenbeckJP

2009 Parallel genetic evolution within and between bacteriophage species of varying degrees of divergence. Genetics 181 225 234

13. SchoustraSE

DebetsAJM

SlakhorstM

HoekstraRF

2007 Mitotic recombination accelerates adaptation in the fungus Aspergillus nidulans. PLoS Genet 3 e68 doi:10.1371/journal.pgen.0030068

14. WoodTE

BurkeJM

RiesebergLH

2005 Parallel genotypic adaptation: when evolution repeats itself. Genetica 123 157 170

15. TravisanoM

MongoldJA

BennettAF

LenskiRE

1995 Experimental tests of the roles of adaptation, chance, and history in evolution. Science 267 87 90

16. WoodsR

SchneiderD

WinkworthCL

RileyMA

LenskiRE

2006 Tests of parallel molecular evolution in a long-term experiment with Escherichia coli. Proc Natl Acad Sci U S A 103 9107 9112

17. BlountZD

BorlandCZ

LenskiRE

2008 Historical contingency and the evolution of a key innovation in an experimental population of Escherichia coli. Proc Natl Acad Sci U S A 105 7899 7906

18. StemmerWP

1994 Rapid evolution of a protein in vitro by DNA shuffling. Nature 370 389 391

19. BarlowM

HallBG

2002 Predicting evolutionary potential: in vitro evolution accurately reproduces natural evolution of the TEM β-lactamase. Genetics 160 823 832

20. BershteinS

SegalM

BekermanR

TokurikiN

TawfikDS

2006 Robustness-epistasis link shapes the fitness landscape of a randomly drifting protein. Nature 444 929 932

21. BarlowM

HallBG

2003 Experimental prediction of the natural evolution of antibiotic resistance. Genetics 163 1237 1241

22. VakulenkoSB

GerykB

KotraLP

MobasheryS

LernerSA

1998 Selection and characterization of β-lactam-β-lactamase inactivator-resistant mutants following PCR mutagenesis of the TEM-1 β-lactamase gene. Antimicrob Agents Chemother 42 1542 1548

23. HallBG

2002 Predicting evolution by in vitro evolution requires determining evolutionary pathways. Antimicrob Agents Chemother 46 3035 3038

24. WeinreichDM

DelaneyNF

DePristoMA

HartlDL

2006 Darwinian evolution can follow only very few mutational paths to fitter proteins. Science 312 111 114

25. GiakkoupiP

TzelepiE

TassiosPT

LegakisNJ

TzouvelekisLS

2000 Detrimental effect of the combination of R164S with G238S in TEM-1 β-lactamase on the extended-spectrum activity conferred by each single mutation. J Antimicrob Chemother 45 101 104

26. ZaccoloM

GherardiE

1999 The effect of high-frequency random mutagenesis on in vitro protein evolution: a study on TEM-1 β-lactamase. J Mol Biol 285 775 783

27. HeckyJ

MullerKM

2005 Structural perturbation and compensation by directed evolution at physiological temperature leads to thermostabilization of β-lactamase. Biochemistry 44 12640 12654

28. BrownNG

PenningtonJM

HuangW

AyvazT

PalzkillT

2010 Multiple global suppressors of protein stability defects facilitate the evolution of extended-spectrum TEM β-lactamases. J Mol Biol 404 832 846

29. KatherI

JakobRP

DobbekH

SchmidFX

2008 Increased folding stability of TEM-1 β-lactamase by in vitro selection. J Mol Biol 383 238 251

30. OrenciaMC

YoonJS

NessJE

StemmerWPC

StevensRC

2001 Predicting the emergence of antibiotic resistance by directed evolution and structural analysis. Nat Struct Biol 8 238 242

31. CantuC

HuangWZ

PalzkillT

1997 Cephalosporin substrate specificity determinants of TEM-1 β-lactamase. J Biol Chem 272 29144 29150

32. SalverdaMLM

De VisserJAGM

BarlowM

2010 Natural evolution of TEM-1 β-lactamase: experimental reconstruction and clinical relevance. FEMS Microbiol Rev 34 1015 1036

33. HuangWZ

LeQQ

LaroccoM

PalzkillT

1994 Effect of Threonine-to-Methionine substitution at position 265 on structure and function of TEM-1 β-lactamase. Antimicrob Agents Chemother 38 2266 2269

34. FershtAR

1985 Enzyme Structure and Mechanism. New York Freeman 475

35. FirthAE

PatrickWM

2005 Statistics of protein library construction. Bioinformatics 21 3314 3315

36. DePristoMA

WeinreichDM

HartlDL

2005 Missense meanderings in sequence space: a biophysical view of protein evolution. Nat Rev Genet 6 678 687

37. TokurikiN

TawfikDS

2009 Stability effects of mutations and protein evolvability. Curr Opin Struct Biol 19 596 604

38. BershteinS

GoldinK

TawfikDS

2008 Intense neutral drifts yield robust and evolvable consensus proteins. J Mol Biol 379 1029 1044

39. AmblerRP

CoulsonAFW

FrereJM

GhuysenJM

JorisB

1991 A standard numbering scheme for the class-A β-lactamases. Biochem J 276 269 270

40. SutcliffeJG

1978 Nucleotide sequence of ampicillin resistance gene of Escherichia coli plasmid pBR322. Proc Natl Acad Sci U S A 75 3737 3741

Štítky
Genetika Reprodukčná medicína

Článok vyšiel v časopise

PLOS Genetics


2011 Číslo 3
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#